KP415.E01: "A Multicenter, Dose-optimized, double-blind, randomized, placebo-controlled, parallel efficacy laboratory classroom study with KP415 in children with attention-deficit/hyperactivity disorder"
Clinical Trial Grant
Administered By
Psychiatry, Child & Family Mental Health & Community Psychiatry
Awarded By
KemPharm, Inc
Start Date
November 7, 2017
End Date
October 1, 2019
Administered By
Psychiatry, Child & Family Mental Health & Community Psychiatry
Awarded By
KemPharm, Inc
Start Date
November 7, 2017
End Date
October 1, 2019